These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31323949)

  • 1. Methylation Dynamics of
    Malpeli G; Innamorati G; Decimo I; Bencivenga M; Nwabo Kamdje AH; Perris R; Bassi C
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31323949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long non-coding RNA
    Calanca N; Paschoal AP; Munhoz ÉP; Galindo LT; Barbosa BM; Caldeira JRF; Oliveira RA; Cavalli LR; Rogatto SR; Rainho CA
    Epigenetics; 2019 Aug; 14(8):741-750. PubMed ID: 31062660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis.
    Dammann R; Schagdarsurengin U; Strunnikova M; Rastetter M; Seidel C; Liu L; Tommasi S; Pfeifer GP
    Histol Histopathol; 2003 Apr; 18(2):665-77. PubMed ID: 12647816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.
    Endoh H; Yatabe Y; Shimizu S; Tajima K; Kuwano H; Takahashi T; Mitsudomi T
    Int J Cancer; 2003 Aug; 106(1):45-51. PubMed ID: 12794755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor RASSF1A in human carcinogenesis: an update.
    Dammann R; Schagdarsurengin U; Seidel C; Strunnikova M; Rastetter M; Baier K; Pfeifer GP
    Histol Histopathol; 2005 Apr; 20(2):645-63. PubMed ID: 15736067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1.
    Volodko N; Salla M; Zare A; Abulghasem el-A; Vincent K; Benesch MG; McMullen TP; Bathe OF; Postovit L; Baksh S
    Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27294960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
    PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer.
    Dammann RH; Richter AM; Jiménez AP; Woods M; Küster M; Witharana C
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells.
    Castanotto D; Tommasi S; Li M; Li H; Yanow S; Pfeifer GP; Rossi JJ
    Mol Ther; 2005 Jul; 12(1):179-83. PubMed ID: 15963934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy.
    García-Gutiérrez L; McKenna S; Kolch W; Matallanas D
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the tumor suppressor gene RASSF1A in human tumors.
    Pfeifer GP; Dammann R
    Biochemistry (Mosc); 2005 May; 70(5):576-83. PubMed ID: 15948711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
    Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
    Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.